SWK Holdings Provides $16MM Facility to Imprimis Pharmaceuticals
SWK Holdings provided a five-year, $16 million debt facility to Imprimis Pharmaceuticals.
July 21, 2017
Imprimis Pharmaceuticals | KEMA Partners | SWK Holdings | WestCape Advisors
Sam Nickerson